An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone checked in after four weekly injections of semaglutide at the usual starter dose (0.25 mg) and reported steady weight loss of about 1.5–2 pounds per week. They’re also strength training, running, and tracking their food, and they haven’t had any bad side effects so far. Their clinician agreed to keep them on the same low dose for now. Semaglutide is the drug in Ozempic and Wegovy. In plain terms, it acts like a natural gut hormone that tells your brain you’re full and slows how fast food leaves your stomach. That makes people feel less hungry and helps them eat less without constant hunger. Doctors usually start with a low “starter” dose to reduce side effects, then gradually increase it over weeks. What this little update actually shows is one person’s experience, not a controlled study. They’ve had four doses at 0.25 mg and are losing about 1.5–2 pounds per week while also exercising and eating less. That’s a meaningful pace for weight loss, but we can’t say how much of it comes from the drug versus the exercise and calorie tracking. It’s anecdotal evidence — useful as a single example, but not proof of how everyone will respond. Why this matters is practical: many people worry about side effects or wonder how long they’ll stay on the starter dose and whether it will work. This note suggests some people tolerate the starter dose well and see steady weight loss while being active and calorie-aware. If you’re considering semaglutide, it’s helpful to know that some clinicians keep people on the low dose if they’re doing well and not having problems, rather than immediately pushing higher doses. There are important caveats. One person’s smooth experience doesn’t guarantee the same for others. Semaglutide can cause nausea, vomiting, constipation, or low blood sugar in some people, and there are longer-term unknowns and cost and access issues. It’s a prescription medication and should be used under medical supervision; dose changes are made by clinicians based on benefits and side effects. If you have certain medical conditions or are pregnant, semaglutide may not be appropriate. Bottom line: This report shows one person tolerating the starter semaglutide dose and losing weight steadily, but it’s an anecdote — talk with a clinician about risks, expectations, and whether staying on a low dose is right for you.
Source: r/Semaglutide